These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 12859322)
1. Fat distribution is altered in HIV-infected men without clinical evidence of the HIV lipodystrophy syndrome. Kosmiski L; Kuritzkes D; Hamilton J; Sharp T; Lichtenstien K; Hill J; Eckel R HIV Med; 2003 Jul; 4(3):235-40. PubMed ID: 12859322 [TBL] [Abstract][Full Text] [Related]
2. Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy. Huang JS; Rietschel P; Hadigan CM; Rosenthal DI; Grinspoon S AIDS; 2001 May; 15(8):975-82. PubMed ID: 11399979 [TBL] [Abstract][Full Text] [Related]
3. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry. Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321 [TBL] [Abstract][Full Text] [Related]
4. Reduced intravertebral bone marrow fat in HIV-infected men. Huang JS; Mulkern RV; Grinspoon S AIDS; 2002 Jun; 16(9):1265-9. PubMed ID: 12045492 [TBL] [Abstract][Full Text] [Related]
5. Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome. Kosmiski LA; Kuritzkes DR; Lichtenstein KA; Glueck DH; Gourley PJ; Stamm ER; Scherzinger AL; Eckel RH AIDS; 2001 Oct; 15(15):1993-2000. PubMed ID: 11600828 [TBL] [Abstract][Full Text] [Related]
6. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population. Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291 [TBL] [Abstract][Full Text] [Related]
7. Fat Mass Ratio in Brazilian HIV-infected Patients Under Antiretroviral Therapy and Its Relationship With Anthropometric Measurents. Bicudo Bruno Nogueira A; Abreu JM; Mesquita Villela M; Boracini Sanchez AE; Silva Chaves B; Setubal S; Coca Velarde LG; Cruz Filho RAD; Balarini Lima GA; Soares DV J Clin Densitom; 2020; 23(4):623-629. PubMed ID: 30545683 [TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus-associated lipodystrophy: an objective definition based on dual-energy x-ray absorptiometry-derived regional fat ratios in a South Asian population. Asha HS; Seshadri MS; Paul TV; Abraham OC; Rupali P; Thomas N Endocr Pract; 2012; 18(2):158-69. PubMed ID: 21856599 [TBL] [Abstract][Full Text] [Related]
9. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. Miller J; Carr A; Emery S; Law M; Mallal S; Baker D; Smith D; Kaldor J; Cooper DA HIV Med; 2003 Jul; 4(3):293-301. PubMed ID: 12859330 [TBL] [Abstract][Full Text] [Related]
10. Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy. Brambilla P; Bricalli D; Sala N; Renzetti F; Manzoni P; Vanzulli A; Chiumello G; di Natale B; ViganĂ² A AIDS; 2001 Dec; 15(18):2415-22. PubMed ID: 11740192 [TBL] [Abstract][Full Text] [Related]
11. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use. Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360 [TBL] [Abstract][Full Text] [Related]
12. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. Carr A; Samaras K; Burton S; Law M; Freund J; Chisholm DJ; Cooper DA AIDS; 1998 May; 12(7):F51-8. PubMed ID: 9619798 [TBL] [Abstract][Full Text] [Related]
13. Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome. Torriani M; Hadigan C; Jensen ME; Grinspoon S J Appl Physiol (1985); 2003 Sep; 95(3):1005-10. PubMed ID: 12766180 [TBL] [Abstract][Full Text] [Related]
14. Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism. Samaras K; Wand H; Law M; Emery S; Cooper DA; Carr A Curr HIV Res; 2009 Jul; 7(4):454-61. PubMed ID: 19601783 [TBL] [Abstract][Full Text] [Related]
15. Adipocyte-derived hormone levels in HIV lipodystrophy. Kosmiski L; Kuritzkes D; Lichtenstein K; Eckel R Antivir Ther; 2003 Feb; 8(1):9-15. PubMed ID: 12713059 [TBL] [Abstract][Full Text] [Related]
16. Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging. Engelson ES; Kotler DP; Tan Y; Agin D; Wang J; Pierson RN; Heymsfield SB Am J Clin Nutr; 1999 Jun; 69(6):1162-9. PubMed ID: 10357734 [TBL] [Abstract][Full Text] [Related]
17. Regional body fat distribution in HIV-infected patients with lipodystrophy. Dinges WL; Chen D; Snell PG; Weatherall PT; Peterson DM; Garg A J Investig Med; 2005 Jan; 53(1):15-25. PubMed ID: 16025877 [TBL] [Abstract][Full Text] [Related]
18. Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children. ViganĂ² A; Mora S; Testolin C; Beccio S; Schneider L; Bricalli D; Vanzulli A; Manzoni P; Brambilla P J Acquir Immune Defic Syndr; 2003 Apr; 32(5):482-9. PubMed ID: 12679698 [TBL] [Abstract][Full Text] [Related]
19. Progression of lipodystrophy (LD) with continued thymidine analogue usage: long-term follow-up from a randomized clinical trial (the PIILR study). Martin A; Smith D; Carr A; Hoy J; Chuah J; Mallal S; Law M; Clements M; Cooper DA; HIV Clin Trials; 2004; 5(4):192-200. PubMed ID: 15472793 [TBL] [Abstract][Full Text] [Related]
20. Comparison of dual-energy X-ray absorptiometry machines for measuring fat distribution changes of HIV-associated lipodystrophy. Yang Y; Zhu WD; Paton NI Antivir Ther; 2004 Oct; 9(5):771-8. PubMed ID: 15535415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]